TARO LVT 250 (Levetiracetam 250 mg)
Pill imprint TARO LVT 250 has been identified as Levetiracetam 250 mg.
Levetiracetam is used in the treatment of seizures; epilepsy; bipolar disorder; new daily persistent headache; neuralgia (and more), and belongs to the drug class pyrrolidine anticonvulsants. Risk cannot be ruled out during pregnancy. Levetiracetam 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- TARO LVT 250
- Strength:
- 250 mg
- Color:
- Blue
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Pyrrolidine anticonvulsants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Taro Pharmaceuticals U.S.A., Inc.
- National Drug Code (NDC):
- 51672-4141
- Inactive Ingredients:
- silicon dioxide
corn starch
magnesium stearate
povidone
magnesium silicate
FD&C Blue No. 2
indigotindisulfonate sodium
aluminum oxide
hypromelloses
polyethylene glycol
titanium dioxide
Note: Inactive ingredients may vary.
More about levetiracetam
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 238 Reviews – Add your own review/rating
- Drug class: pyrrolidine anticonvulsants
Consumer resources
- Levetiracetam
- Levetiracetam extended-release tablets
- Levetiracetam solution
- Levetiracetam tablets
- Levetiracetam (Advanced Reading)
- Levetiracetam Intravenous (Advanced Reading)
Other brands: Keppra, Keppra XR, Spritam
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
